Purchase Order 75N93024P00160
Award Date 12/20/23
Potential Completion Date 11/25/24
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC for one catalog item #834083, HGMD Data Download for clinical use by a medium-sized enterprise. The place of performance will be Qiagen's Germantown, Maryland division. The period of performance is January 1, 2024 through November 25, 2024. No set aside designation or subcontractors were indicated....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,348.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The service agreement, which does not have a set-aside designation, is for Qiagen's QIAGILLITY products and services. Qiagen is an experienced federal contractor, having provided a range of molecular diagnostics, biotechnology, and bioinformatics...
- Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $13,166 to Qiagen, LLC of Germantown, Maryland. The one-year contract provides full agreement service for two QIACUBE HT/QIAXTRACTOR platforms from July 1, 2023 to June 30, 2024. Qiagen, LLC is a subsidiary of Qiagen N.V. and will perform the entirety of the contract within the United States. The award is likely in...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $30,468 firm fixed price purchase order to Qiagen, LLC. Qiagen will provide products and services to NIH under the contract, which runs from August 2023 through August 2024. Qiagen is a subsidiary of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. The place of performance is...
- This federal contract award to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V., is for maintenance services. The $4,348.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract does not have a set-aside designation. Qiagen is a leading provider of molecular diagnostic products and services to federal agencies, supporting critical...
- This is a firm-fixed-price BPA call order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Qiagen, LLC for $49,926.24. The order is for reagents under AMBIS# 1707336. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which provides sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. Qiagen has a history of federal contract...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $9,445.00 firm fixed-price contract does not have a set-aside designation. The contract supports NIAID's biomedical research, public health, and healthcare programs through the provision of Qiagen's sample and assay technologies, including...
- The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...